Immune resolution mechanisms in inflammatory arthritis
暂无分享,去创建一个
M. Perretti | L. Norling | D. Cooper | Mauro Perretti | J. Dalli | Jesmond Dalli | Lucy V. Norling | Dianne Cooper | Jesmond Dalli
[1] L. Baum,et al. Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration , 2006, Laboratory Investigation.
[2] M. Ehrenstein,et al. Regulatory T‐cells in systemic lupus erythematosus and rheumatoid arthritis , 2011, FEBS letters.
[3] J. Markworth,et al. Divergent shifts in lipid mediator profile following supplementation with n‐3 docosapentaenoic acid and eicosapentaenoic acid , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] F. Montecucco,et al. Sulphasalazine accelerates apoptosis in neutrophils exposed to immune complex: Role of caspase pathway , 2009, Clinical and experimental pharmacology & physiology.
[5] Benhur Lee,et al. Galectin-1 Regulates Tissue Exit of Specific Dendritic Cell Populations , 2015, The Journal of Biological Chemistry.
[6] M. Perretti,et al. Inhibitory control of endothelial galectin‐1 on in vitro and in vivo lymphocyte trafficking , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] M. Perretti,et al. Connections in pharmacology: innovation serving translational medicine. , 2014, Drug discovery today.
[8] J. Schwab,et al. Anesthetics Impact the Resolution of Inflammation , 2008, PloS one.
[9] B. Cronstein,et al. Methotrexate—how does it really work? , 2010, Nature Reviews Rheumatology.
[10] Trevor A. Mori,et al. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.
[11] D. Irimia,et al. Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis , 2016, JCI insight.
[12] J. Pelletier,et al. Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis , 2009, Arthritis research & therapy.
[13] M. Perretti,et al. Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of Peritonitis1 , 2006, The Journal of Immunology.
[14] N. Gibran,et al. Spatial and Temporal Localization of the Melanocortin 1 Receptor and Its Ligand α–Melanocyte-Stimulating Hormone during Cutaneous Wound Repair , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[15] Yu Lin,et al. Augmentation of Myocardial Production of 15-Epi-Lipoxin-A4 by Pioglitazone and Atorvastatin in the Rat , 2006, Circulation.
[16] F. Blanco,et al. Effect of hydrogen sulfide sources on inflammation and catabolic markers on interleukin 1β-stimulated human articular chondrocytes. , 2014, Osteoarthritis and cartilage.
[17] K. Varani,et al. Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? , 2016, Trends in pharmacological sciences.
[18] K. Varani,et al. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release , 2011, Arthritis research & therapy.
[19] R. Lechler,et al. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. , 2007, Blood.
[20] G. Majno. Inflammation and infection: historic highlights. , 1982, Monographs in pathology.
[21] M. Perretti,et al. Evidence for an Anti-Inflammatory Loop Centered on Polymorphonuclear Leukocyte Formyl Peptide Receptor 2/Lipoxin A4 Receptor and Operative in the Inflamed Microvasculature , 2011, The Journal of Immunology.
[22] K. Brown,et al. Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. , 2011, Arthritis and rheumatism.
[23] S. Moncada,et al. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Daoussis,et al. ACTH as a treatment for acute crystal-induced arthritis: update on clinical evidence and mechanisms of action. , 2014, Seminars in arthritis and rheumatism.
[25] K. Urabe,et al. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. , 2007, The Journal of rheumatology.
[26] R. Medzhitov. Origin and physiological roles of inflammation , 2008, Nature.
[27] M. Perretti,et al. A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. , 2013, Blood.
[28] D. Gilroy,et al. Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.
[29] V. Kuchroo,et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity , 2005, Nature Immunology.
[30] T. Luger,et al. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. , 2009, Arthritis and rheumatism.
[31] E. Motta,et al. The precursor of resolvin D series and aspirin‐triggered resolvin D1 display anti‐hyperalgesic properties in adjuvant‐induced arthritis in rats , 2011, British journal of pharmacology.
[32] G. Rabinovich,et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 , 2009, Nature Immunology.
[33] C. Serhan,et al. Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3 , 2016, PloS one.
[34] Yan Lu,et al. Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators. , 2005, Journal of lipid research.
[35] T. Niki,et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. , 2007, Arthritis and rheumatism.
[36] M. Perretti,et al. Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses , 2013, Proceedings of the National Academy of Sciences.
[37] M. Perretti,et al. Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation. , 2015, Trends in pharmacological sciences.
[38] M. Perretti,et al. Endogenous Galectin-1 Exerts Tonic Inhibition on Experimental Arthritis , 2013, The Journal of Immunology.
[39] C. Serhan,et al. Inhaled Carbon Monoxide Accelerates Resolution of Inflammation via Unique Proresolving Mediator–Heme Oxygenase-1 Circuits , 2013, The Journal of Immunology.
[40] L. Joosten,et al. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra , 2015, Annals of the rheumatic diseases.
[41] L. Joosten,et al. 12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis , 2009, The Journal of Immunology.
[42] C. Serhan,et al. Proresolving Nanomedicines Activate Bone Regeneration in Periodontitis , 2015, Journal of dental research.
[43] B. Levy,et al. Maresin 1 biosynthesis during platelet–neutrophil interactions is organ-protective , 2014, Proceedings of the National Academy of Sciences.
[44] M. Hamberg,et al. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. R. Moore,et al. Resolution of Inflammation in Murine Autoimmune Arthritis Is Disrupted by Cyclooxygenase-2 Inhibition and Restored by Prostaglandin E2-Mediated Lipoxin A4 Production , 2010, The Journal of Immunology.
[46] D. Gilroy,et al. New insights into the resolution of inflammation. , 2015, Seminars in immunology.
[47] F. D’Acquisto,et al. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation , 2009, Nature Reviews Immunology.
[48] M. Perretti,et al. Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis , 2013, EMBO molecular medicine.
[49] R. Hannon,et al. Corrections: Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation , 2011, The Journal of Immunology.
[50] H2S transiently blocks IL‐6 expression in rheumatoid arthritic fibroblast‐like synoviocytes and deactivates p44/42 mitogen‐activated protein kinase , 2010, Cell biology international.
[51] O. Rådmark,et al. Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids , 2009, Arthritis research & therapy.
[52] C. Reutelingsperger,et al. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice , 2014, Hepatology.
[53] S. Yamamoto,et al. Lipoxin synthase activity of human platelet 12-lipoxygenase. , 1993, The Biochemical journal.
[54] T. Schall,et al. Overcoming hurdles in developing successful drugs targeting chemokine receptors , 2011, Nature Reviews Immunology.
[55] L. O’Driscoll,et al. Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.
[56] B. Pesce,et al. Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin , 2015, PLoS neglected tropical diseases.
[57] M. Perretti,et al. Molecular engineering of short half-life small peptides (VIP, αMSH and γ3MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics , 2011, Annals of the rheumatic diseases.
[58] S. Shuto,et al. Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS , 2015, Analytical and Bioanalytical Chemistry.
[59] B. Levy,et al. Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes , 2017, Critical care medicine.
[60] M. Perretti,et al. Control of Myeloid Cell Trafficking in Resolution , 2013, Journal of Innate Immunity.
[61] I. McInnes,et al. Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases , 2015, Pharmacological Reviews.
[62] M. Hersberger,et al. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation , 2013, Lipids in Health and Disease.
[63] C. Weber,et al. Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment. , 2015, Circulation research.
[64] Ruth E. Hartley,et al. An integrated view. , 1973 .
[65] M. Perretti,et al. Annexin A1 Mediates Hydrogen Sulfide Properties in the Control of Inflammation , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[66] I. McInnes,et al. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis , 2015, Annals of the rheumatic diseases.
[67] Charles N. Serhan,et al. Molecular circuits of resolution: formation and actions of resolvins and protectins , 2005, The Journal of Immunology.
[68] G. Rabinovich,et al. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. , 2001, The Journal of rheumatology.
[69] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[70] O. Farokhzad,et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. , 2015, The Journal of clinical investigation.
[71] R. Clark,et al. Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation , 2010, The Journal of Immunology.
[72] F. Dell’Accio,et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis , 2015, Science Translational Medicine.
[73] Oliver Soehnlein,et al. Resolution of inflammation: an integrated view , 2013, EMBO molecular medicine.
[74] R. Burgos-Vargas,et al. A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis , 2013, Scandinavian journal of rheumatology.
[75] M. Perretti,et al. Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3. , 2014, The American journal of pathology.
[76] C. Serhan,et al. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. , 2015, Seminars in immunology.
[77] N. Petasis,et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. , 2002, Journal of the American Society of Nephrology : JASN.
[78] R. Cummings,et al. Dimeric Galectin-1 Induces Surface Exposure of Phosphatidylserine and Phagocytic Recognition of Leukocytes without Inducing Apoptosis* , 2003, Journal of Biological Chemistry.
[79] J. Wallace,et al. Gaseous mediators in resolution of inflammation. , 2015, Seminars in immunology.
[80] M. Perretti,et al. Biased Agonism as a Novel Strategy To Harness the Proresolving Properties of Melanocortin Receptors without Eliciting Melanogenic Effects , 2015, The Journal of Immunology.
[81] M. Perretti,et al. Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors , 2012, Cell Death and Differentiation.
[82] C. Buckley,et al. The role of stromal cells in the persistence of chronic inflammation , 2013, Clinical and experimental immunology.
[83] Trevor A. Mori,et al. Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta , 2013, Journal of Lipid Research.
[84] P. Grieco,et al. Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[85] C. Serhan,et al. Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins1 , 2005, The Journal of Immunology.
[86] J. M. Cousin,et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. , 1999, Journal of immunology.
[87] C. Müller,et al. Selective Activation of Adenosine A2A Receptors on Immune Cells by a CD73-Dependent Prodrug Suppresses Joint Inflammation in Experimental Rheumatoid Arthritis , 2012, Science Translational Medicine.
[88] Chuan Wu,et al. Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. , 2014, Immunity.
[89] C. Serhan,et al. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. , 2012, Blood.
[90] J. Shaw,et al. Chemokine blockers--therapeutics in the making? , 2006, Trends in pharmacological sciences.
[91] B. Levy,et al. Lovastatin Decreases Acute Mucosal Inflammation Via 15-epi-Lipoxin A4 , 2010, Mucosal Immunology.
[92] J. Schifferli,et al. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. , 2004, Blood.
[93] Trinidad Montero-Melendez,et al. ACTH: The forgotten therapy. , 2015, Seminars in immunology.
[94] T. Niki,et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. , 2008, Clinical immunology.
[95] J. Filep,et al. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation , 2012, Proceedings of the National Academy of Sciences.
[96] L. Baum,et al. Apoptosis of T cells mediated by galectin-1 , 1995, Nature.
[97] J. McQualter,et al. Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease , 2012, Proceedings of the National Academy of Sciences.
[98] D. Gilroy,et al. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. , 2014, Immunity.
[99] A. Dief,et al. Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis. , 2015, European review for medical and pharmacological sciences.
[100] C. Serhan,et al. Human Milk Proresolving Mediators Stimulate Resolution of Acute Inflammation , 2015, Mucosal Immunology.
[101] Y. Kawaoka,et al. The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza , 2013, Cell.
[102] F. D’Acquisto,et al. The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis , 2012, Annals of the rheumatic diseases.
[103] H. Christian,et al. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. , 2002, Arthritis and rheumatism.
[104] M. Perretti,et al. Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles. , 2008, Blood.
[105] B. Cronstein,et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. , 1998, The Journal of clinical investigation.
[106] P. Hench,et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. , 1949, Proceedings of the staff meetings. Mayo Clinic.
[107] R. Sapolsky,et al. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. , 2000, Endocrine reviews.
[108] R. Alon,et al. Leukocyte migration into inflamed tissues. , 2014, Immunity.
[109] T. Niki,et al. Immunopathology and Infectious Diseases Endogenous Galectin-1 and Acute Inflammation Emerging Notion of a Galectin-9 Pro-Resolving Effect , 2011 .
[110] S. Quezada,et al. Resolution of acute inflammation bridges the gap between innate and adaptive immunity. , 2014, Blood.
[111] D. Willis,et al. Heme oxygenase: A novel target for the modulation of inflammatory response , 1996, Nature Medicine.
[112] C. Serhan,et al. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. , 2015, American journal of physiology. Lung cellular and molecular physiology.
[113] Christopher Haslett,et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis , 2006, Nature Medicine.
[114] G. Rabinovich,et al. Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis , 1999, The Journal of experimental medicine.
[115] B. Cronstein,et al. Adenosine A2A Receptor Activation Prevents Wear Particle–Induced Osteolysis , 2012, Science Translational Medicine.
[116] M. Perretti. Endogenous mediators that inhibit the leukocyte-endothelium interaction. , 1997, Trends in pharmacological sciences.
[117] J. Wallace,et al. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter , 2015, Nature Reviews Drug Discovery.
[118] A. Gutman,et al. Effects of adrenocorticotropic hormone (ACTH) in gout. , 1950, The American journal of medicine.
[119] I. McInnes,et al. Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm , 2013, Nature Reviews Rheumatology.
[120] C. Piantadosi,et al. Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. , 2014, American journal of physiology. Lung cellular and molecular physiology.
[121] M. Paul-Clark,et al. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. , 2004, Arthritis and rheumatism.
[122] M. Perretti,et al. Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1 , 2016, The Journal of Immunology.
[123] D. Zeldin,et al. Resolvin Infectious Inflammation by Targeting the Host Response. , 2015, The New England journal of medicine.
[124] M. Giera,et al. Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. , 2012, Biochimica et biophysica acta.
[125] Dief Ae,et al. Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis. , 2015 .
[126] J. Wallace,et al. Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[127] M. Perretti,et al. Novel insights into the inhibitory effects of Galectin‐1 on neutrophil recruitment under flow , 2008, Journal of leukocyte biology.
[128] C. Serhan,et al. Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections , 2015, Nature Medicine.
[129] F. Liew,et al. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis , 2015, Proceedings of the National Academy of Sciences.
[130] V. Blaho,et al. 5-Lipoxygenase–Deficient Mice Infected with Borrelia burgdorferi Develop Persistent Arthritis , 2011, The Journal of Immunology.
[131] Charles N. Serhan,et al. Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.
[132] P. Grieco,et al. Melanocortin peptides protect chondrocytes from mechanically induced cartilage injury. , 2014, Biochemical pharmacology.
[133] C. Serhan,et al. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.
[134] T. Niki,et al. Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. , 2009, Clinical immunology.
[135] P. Calder,et al. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis , 2012, British Journal of Nutrition.
[136] S. Grässel,et al. Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research. , 2012, Endocrine reviews.
[137] G. Rabinovich,et al. Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype. , 2013, Prostaglandins & other lipid mediators.
[138] Takanori Nakamura,et al. Galectin-8 and galectin-9 are novel substrates for thrombin. , 2006, Glycobiology.
[139] M. Perretti,et al. Cutting Edge: Humanized Nano-Proresolving Medicines Mimic Inflammation-Resolution and Enhance Wound Healing , 2011, The Journal of Immunology.
[140] M. Perretti,et al. Investigational Analysis Reveals a Potential Role for Neutrophils in Giant-Cell Arteritis Disease Progression , 2014, Circulation research.
[141] M. Teixeira,et al. The Required Role of Endogenously Produced Lipoxin A4 and Annexin-1 for the Production of IL-10 and Inflammatory Hyporesponsiveness in Mice1 , 2007, The Journal of Immunology.
[142] O. Farokhzad,et al. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice , 2015, Science Translational Medicine.